Abstract:DNA interstrand crosslinkers, a chemically diverse group of compounds which also induce alkylation of bases and DNA intrastrand crosslinks, are extensively utilized for cancer therapy. Understanding the cellular response to DNA damage induced by these agents is critical for more effective utilization of these compounds and for the identification of novel therapeutic targets. Importantly, the repair of DNA interstrand crosslinks (ICLs) involves many distinct DNA repair pathways, including nucleotide excision repair, translesion synthesis (TLS), and homologous recombination (HR). Additionally, proteins implicated in the pathophysiology of the multigenic disease Fanconi anemia (FA) have a role in the repair of ICLs that is not well understood. Cells from FA patients are hypersensitive to agents that induce ICLs, therefore FA proteins are potentially novel therapeutic targets. Here we will review current research directed at identifying FA genes and understanding the function of FA proteins in DNA damage responses. We will also examine interactions of FA proteins with other repair proteins and pathways, including signaling networks, which are potentially involved in ICL repair. Potential approaches to the modulation of FA protein function to enhance therapeutic outcome will be discussed. Also, mutation of many genes that encode proteins involved in ICL repair, including FA genes, increases susceptibility to cancer. A better understanding of these pathways is therefore critical for the design of individualized therapies tailored to the genetic profile of a particular malignancy. For this purpose, we will also review evidence for the association of mutation of FA genes with cancer in non-FA patients.

Fan1 Acts with Fanci-Fancd2 to Promote Dna Interstrand Cross-Link Repair

Fanconi Anemia and DNA Interstrand Cross-Link Repair

A Ubiquitin-Binding Protein, Faap20, Links Rnf8-Mediated Ubiquitination to the Fanconi Anemia Dna Repair Network

A FancD2-monoubiquitin Fusion Reveals Hidden Functions of Fanconi Anemia Core Complex in DNA Repair.

A Complex Involved in the Dna Damage Response Network of Fanconi Anemia and Breast Cancer

The Emergence of a Unified Mechanism in the Fanconi Anemia Pathway

Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy

Structural insights into 5' flap DNA unwinding and incision by the human FAN1 dimer

DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications

The Fanconi anemia core complex promotes CtIP-dependent end resection to drive homologous recombination at DNA double-strand breaks

Fanconi anemia proteins participate in a break-induced-replication-like pathway to counter replication stress

Fan1 deficiency results in DNA interstrand cross-link repair defects, enhanced tissue karyomegaly, and organ dysfunction

FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair.

Structure of the FA core ubiquitin ligase closing the ID clamp on DNA

FANCJ is a Structure-specific DNA Helicase Associated with the Maintenance of Genomic G/C Tracts*

Structural Insights into the Function of FANCM‐mediated Complexes

Rad5-dependent DNA Repair Functions of the Saccharomyces Cerevisiae FANCM Protein Homolog Mph1.

Fanconi anaemia and the repair of Watson and Crick DNA crosslinks

The Fanconi Anemia Core Complex Associates with Chromatin During S Phase.

BRMS1 Participates in Regulating Cell Sensitivity to DNA Interstrand Crosslink Damage by Interacting with FANCI

The structure of the FANCM–MHF complex reveals physical features for functional assembly